Novartis, Medtronic and SinoPharm will exit the stem cell-based diabetes therapy developer in an acquisition by Vertex Pharmaceuticals.

The Stanford-backed consumer credit management platform has now raised $110m altogether, and the latest round will fund hiring and technology development.

Novartis, Medtronic and SinoPharm will exit the stem cell-based diabetes therapy developer in an acquisition by Vertex Pharmaceuticals.

After 22 years at Eli Lilly that included laying the groundwork for its corporate venturing activities, senior vice-president of corporate business development Darren Carroll is retiring.

Taiwan Life has provided capital for Bessemer Venture Partners' Century Fund, one of a range of fund investments it has made in 2019.

The unit has hired EquityZen co-founder Shriram Bhashyam as its latest entrepreneur in residence in order to coach employees developing financial technology.

The Capital One and Symantec-backed consumer credit management platform has now raised $110m altogether, and the latest round will fund hiring and technology development.

The home services platform increased its overall funding to nearly $30m in a series B round that included Ferguson Enterprises, Liberty Mutual, The Hartford and State Farm.

AstraZeneca spinoff Viela has raised nearly $390m in funding and has filed for an initial public offering that would also allow 6 Dimensions Capital to exit.

Grant Allen and Varun Jain - both previously recognised by GCV - have been snapped up by Schneider Electric's $565m corporate venturing fund.